Viewing StudyNCT00288028



Ignite Creation Date: 2024-05-05 @ 4:39 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00288028
Status: COMPLETED
Last Update Posted: 2013-11-19
First Post: 2006-02-06

Brief Title: Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization: Barbara Ann Karmanos Cancer Institute

Organization Data

Organization: Barbara Ann Karmanos Cancer Institute
Class: OTHER
Study ID: CDR0000455585
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Barbara Ann Karmanos Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Muneer Abidi
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Barbara Ann Karmanos Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH